Invest in 5,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Twist Bioscience Corporation engages in the manufacture and sale of synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, ...more
Time Frame | TWST | Sector | S&P500 |
---|---|---|---|
1-Week Return | -0.18% | -0.01% | 0.21% |
1-Month Return | -16.85% | -0.55% | 2.48% |
3-Month Return | -12.59% | 8.11% | 9.04% |
6-Month Return | 69.85% | 13.26% | 22.31% |
1-Year Return | 107.31% | 15.92% | 32.44% |
3-Year Return | -70.8% | 30.53% | 36.67% |
5-Year Return | 53.97% | 74.26% | 99.93% |
10-Year Return | 141.07% | 195.01% | 236.66% |
Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 54.38M | 90.10M | 132.33M | 203.56M | 245.11M | [{"date":"2019-09-30","value":22.19,"profit":true},{"date":"2020-09-30","value":36.76,"profit":true},{"date":"2021-09-30","value":53.99,"profit":true},{"date":"2022-09-30","value":83.05,"profit":true},{"date":"2023-09-30","value":100,"profit":true}] |
Cost of Revenue | 47.43M | 61.41M | 80.62M | 119.33M | 155.38M | [{"date":"2019-09-30","value":30.52,"profit":true},{"date":"2020-09-30","value":39.52,"profit":true},{"date":"2021-09-30","value":51.89,"profit":true},{"date":"2022-09-30","value":76.8,"profit":true},{"date":"2023-09-30","value":100,"profit":true}] |
Gross Profit | 6.96M | 28.69M | 51.71M | 84.23M | 89.73M | [{"date":"2019-09-30","value":7.76,"profit":true},{"date":"2020-09-30","value":31.98,"profit":true},{"date":"2021-09-30","value":57.63,"profit":true},{"date":"2022-09-30","value":93.88,"profit":true},{"date":"2023-09-30","value":100,"profit":true}] |
Gross Margin | 12.80% | 31.85% | 39.08% | 41.38% | 36.61% | [{"date":"2019-09-30","value":30.92,"profit":true},{"date":"2020-09-30","value":76.96,"profit":true},{"date":"2021-09-30","value":94.44,"profit":true},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":88.47,"profit":true}] |
Operating Expenses | 115.81M | 146.27M | 204.97M | 333.26M | 296.63M | [{"date":"2019-09-30","value":34.75,"profit":true},{"date":"2020-09-30","value":43.89,"profit":true},{"date":"2021-09-30","value":61.51,"profit":true},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":89.01,"profit":true}] |
Operating Income | (108.85M) | (117.58M) | (153.26M) | (249.02M) | (217.16M) | [{"date":"2019-09-30","value":-10885000000,"profit":false},{"date":"2020-09-30","value":-11757900000,"profit":false},{"date":"2021-09-30","value":-15326000000,"profit":false},{"date":"2022-09-30","value":-24902100000,"profit":false},{"date":"2023-09-30","value":-21715900000,"profit":false}] |
Total Non-Operating Income/Expense | 3.21M | (21.26M) | (700.00K) | 23.73M | 3.44M | [{"date":"2019-09-30","value":13.53,"profit":true},{"date":"2020-09-30","value":-89.59,"profit":false},{"date":"2021-09-30","value":-2.95,"profit":false},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":14.48,"profit":true}] |
Pre-Tax Income | (107.38M) | (139.55M) | (154.03M) | (228.27M) | (203.47M) | [{"date":"2019-09-30","value":-10737700000,"profit":false},{"date":"2020-09-30","value":-13954900000,"profit":false},{"date":"2021-09-30","value":-15402800000,"profit":false},{"date":"2022-09-30","value":-22827400000,"profit":false},{"date":"2023-09-30","value":-20346600000,"profit":false}] |
Income Taxes | 292.00K | 382.00K | (1.93M) | (10.41M) | 1.15M | [{"date":"2019-09-30","value":25.35,"profit":true},{"date":"2020-09-30","value":33.16,"profit":true},{"date":"2021-09-30","value":-167.53,"profit":false},{"date":"2022-09-30","value":-903.73,"profit":false},{"date":"2023-09-30","value":100,"profit":true}] |
Income After Taxes | (107.67M) | (139.93M) | (152.10M) | (217.86M) | (204.62M) | [{"date":"2019-09-30","value":-10766900000,"profit":false},{"date":"2020-09-30","value":-13993100000,"profit":false},{"date":"2021-09-30","value":-15209800000,"profit":false},{"date":"2022-09-30","value":-21786300000,"profit":false},{"date":"2023-09-30","value":-20461800000,"profit":false}] |
Income From Continuous Operations | (107.67M) | (139.93M) | (152.10M) | (217.86M) | (204.62M) | [{"date":"2019-09-30","value":-10766900000,"profit":false},{"date":"2020-09-30","value":-13993100000,"profit":false},{"date":"2021-09-30","value":-15209800000,"profit":false},{"date":"2022-09-30","value":-21786300000,"profit":false},{"date":"2023-09-30","value":-20461800000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-09-30","value":"-","profit":true},{"date":"2020-09-30","value":"-","profit":true},{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}] |
Net Income | (107.67M) | (139.93M) | (152.10M) | (217.86M) | (204.62M) | [{"date":"2019-09-30","value":-10766900000,"profit":false},{"date":"2020-09-30","value":-13993100000,"profit":false},{"date":"2021-09-30","value":-15209800000,"profit":false},{"date":"2022-09-30","value":-21786300000,"profit":false},{"date":"2023-09-30","value":-20461800000,"profit":false}] |
EPS (Diluted) | (3.99) | (3.06) | (3.12) | (4.03) | (3.37) | [{"date":"2019-09-30","value":-399,"profit":false},{"date":"2020-09-30","value":-306,"profit":false},{"date":"2021-09-30","value":-312,"profit":false},{"date":"2022-09-30","value":-403,"profit":false},{"date":"2023-09-30","value":-337,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
TWST | |
---|---|
Cash Ratio | 4.77 |
Current Ratio | 5.98 |
Quick Ratio | 5.51 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
TWST | |
---|---|
ROA (LTM) | -15.87% |
ROE (LTM) | -30.80% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
TWST | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.19 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.81 |
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is. | 1.24 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
TWST | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 7.44 |
P/B | 3.31 |
Price/FCF | NM |
EV/R | 6.60 |
EV/Ebitda | NM |
PEG | NM |
What''s Driving Twist Bioscience Corp''s Surprising 44% Stock Rally?
Precision Dx Products are CE-marked and compliant with EU IVDR 2017/746 regulations Precision Dx Products include Twist Precision Prep and Enrichment Dx Kit, Twist Precision Exome Dx Panel and Twi…
Twist Bioscience Corporation (NASDAQ: TWST) announces CE-marked Precision Dx Products compliant with EU IVDR regulations, including Twist Precision Prep and Enrichment Dx Kit, Twist Precision Exome Dx Panel, and Twist Precision Exome Dx Kit. The products aim to facilitate panel sequencing within clinical settings, meeting high quality standards. Twist collaborates with Platomics to streamline documentation generation and regulatory compliance. CEO Emily M. Leproust highlights the significance of IVDR certification for diagnostic tests and the company''s commitment to supporting European customers.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced European Union (EU) in vitro diagnostic regulations (IVDR) compliant Twist Precision Dx next-generation sequencing (NGS) Products. In accordance with the IVD regulations put in place by the EU to ensure the safety and quality of in vitro diagnostic medical devices, Twist’s
Twist Bioscience Corp (TWST) share price today is $34.22
Yes, Indians can buy shares of Twist Bioscience Corp (TWST) on Vested. To buy
Yes, you can purchase fractional shares of Twist Bioscience Corp (TWST) via the Vested app. You can start investing in Twist Bioscience Corp (TWST) with a minimum investment of $1.
You can invest in shares of Twist Bioscience Corp (TWST) via Vested in three simple steps:
The 52-week high price of Twist Bioscience Corp (TWST) is 43.21. The 52-week low price of Twist Bioscience Corp (TWST) is 11.46.
The price-to-earnings (P/E) ratio of Twist Bioscience Corp (TWST) is NM
The price-to-book (P/B) ratio of Twist Bioscience Corp (TWST) is 3.31
The dividend yield of Twist Bioscience Corp (TWST) is 0.00%
The market capitalization of Twist Bioscience Corp (TWST) is $1.98B
The stock symbol (or ticker) of Twist Bioscience Corp is TWST